Triptorelin Market Size

Triptorelin Market Size

Triptorelin Market size was valued at over USD 910 million in 2022. Driven by the growing occurrence of endometriosis across the global female population, industry is expected to grow at over 5% CAGR from 2023 to 2032. 

To get key market trends

  Download Free Sample

Endometriosis is a disease that leads to scar tissue formation within the pelvis due to a chronic inflammatory response caused by the presence of endometrium outside the uterus. As per estimates, around 176 million women across the globe, around one in ten, suffer from endometriosis in their reproductive years, typically between the ages of 15 and 49. Triptorelin is efficacious in alleviating the pain symptoms caused by endometriosis. It has a favorable safety profile and has also been shown to improve reproductive function. Subsequently, it is commonly used to treat deep infiltrating endometriosis (DIE) among women.

Steep prices of triptorelin drugs may hamper industry outlook

Despite an extensive customer pool, triptorelin market faces a major challenge in the form of the high manufacturing cost of triptorelin drugs, which translates into steep medication prices for customers. Given that the raw materials utilized are specific to the drug, the quality of raw materials used in drug development is crucial, which further elevates costs. Meanwhile, the complexity of triptorelin manufacturing process, which entails a wide range of biological or chemical processes, is also impeding product adoption by limiting product availability to those who can afford it.